Nebivolol (Nebivolol Hydrochloride)

Nebivolol, the active ingredient in Nebivolol, is a beta blocker presented as a tablet for oral use. It treats hypertension in adult patients by lowering blood pressure and improving vascular function.

GNH USA supplies Nebivolol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nebivolol is a selective β1‑adrenergic blocker used in the management of arterial hypertension and related cardiovascular conditions. - Hypertension: lowers systolic and diastolic blood pressure in patients with essential hypertension. - Primary hypertension: improves vascular tone and reduces peripheral resistance. - Essential hypertension: helps prevent long‑term cardiovascular complications associated with high blood pressure.

Nebivolol may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Headache: mild to moderate intensity. - Dizziness or light‑headedness, especially on standing. - Fatigue or tiredness. - Nausea or mild gastrointestinal upset. - Bradycardia: heart rate slower than normal. - Peripheral edema: swelling of the lower limbs.

Serious or Rare Side Effects: - Severe bradycardia or heart block requiring medical attention. - Marked hypotension with risk of syncope. - Bronchospasm or worsening asthma symptoms. - Allergic reactions such as rash, pruritus, or angioedema. - Hepatic dysfunction or elevated liver enzymes. - Acute heart failure decompensation.

When prescribing or dispensing Nebivolol, consider the following safety measures. - Blood pressure monitoring: regularly assess to ensure therapeutic control. - Heart rate assessment: watch for excessive bradycardia. - Asthma or chronic obstructive pulmonary disease: use with caution due to potential bronchoconstriction. - Discontinuation: avoid abrupt cessation; taper under medical supervision. - Renal or hepatic impairment: dose adjustment may be required. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Nebivolol can interact with several drug classes; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Other beta‑blockers: additive negative chronotropic effects. - Calcium‑channel blockers (e.g., verapamil, diltiazem): may cause profound bradycardia or AV block. - Strong CYP2D6 inhibitors (e.g., paroxetine, fluoxetine): increase nebivolol plasma concentrations.

Moderate Interactions (Monitor Closely):\n- Diuretics: may enhance hypotensive effect. - ACE inhibitors or ARBs: combined use can lead to excessive blood pressure lowering. - NSAIDs: may reduce antihypertensive efficacy. - Antiarrhythmic agents (e.g., amiodarone): potential for conduction disturbances. - Antidiabetic drugs: monitor glucose as beta‑blockade may mask hypoglycaemia symptoms.